Your browser doesn't support javascript.
loading
Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccine.
Smola, A; Samadzadeh, S; Müller, L; Adams, O; Homey, B; Albrecht, P; Meller, S.
Afiliação
  • Smola A; Department of Dermatology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.
  • Samadzadeh S; Department of Neurology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.
  • Müller L; Institute of Virology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.
  • Adams O; Institute of Virology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.
  • Homey B; Department of Dermatology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.
  • Albrecht P; Department of Neurology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.
  • Meller S; Department of Dermatology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.
J Eur Acad Dermatol Venereol ; 35(11): e743-e745, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34310766
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Anafilaxia Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Anafilaxia Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article